m.almeida
TL2 Moderator · Nairobi
Contributes reviews on supplier material. Based in Nairobi.
Joined 23 September 2024 · last posted 4d
84 posts, newest first. Showing up to 150.
-
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #12 · Compounds › Retatrutide · 24 Jul 2026 · 0 likes On post #8 — agreed on the reasoning, with one qualification. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #61 · Access › Insurance & coverage · 23 Jul 2026 · 3 likes This follows post #58 rather than contradicting it. Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and…
-
[2026 update] Documenting an adverse event properly Replied, post #19 · Safety › Adverse events · 23 Jul 2026 · 0 likes Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
Why the Start Here categories exist, and what they are not for Replied, post #17 · Start Here › Welcome · 20 Jul 2026 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #105 · Analytics › Home & field testing · 20 Jul 2026 · 26 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #102 · Sourcing › Independent verification · 18 Jul 2026 · 33 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Substitution between formats during a shortage — what changed since Replied, post #13 · Access › Shortages · 14 Jul 2026 · 3 likes post #12 is right about the mechanism and I think understates the practical bit. International supply chains: a shortage in one country does not mean shortage in…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #128 · Start Here › How to Ask · 14 Jul 2026 · 0 likes post #127 is right about the mechanism and I think understates the practical bit. What you have already read matters. Saying "I read the maintained page on this and I…
-
Common supplements people ask about, assessed one at a time Replied, post #23 · Practice › Interactions · 8 Jul 2026 · 0 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Journal club: what we got wrong in an earlier session Replied, post #52 · Evidence › Journal club · 4 Jul 2026 · 7 likes post #51 is right about the mechanism and I think understates the practical bit. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to…
-
Aggregate verification data across the directory, with caveats Replied, post #23 · Sourcing › Independent verification · 1 Jul 2026 · 13 likes This follows post #20 rather than contradicting it. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #75 · Analytics › Home & field testing · 30 Jun 2026 · 17 likes Coming back to post #73, because the follow-up matters more than the original answer. Why third-party testing is stronger: a home test run by the person who made the…
-
The anatomy of a question that gets answered within an hour Replied, post #90 · Start Here › How to Ask · 25 Jun 2026 · 4 likes post #89 answers the question as asked. The question underneath it is different. What you have already read matters. Saying "I read the maintained page on this and I…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #5 · Compounds › Secretagogues & GH axis · 22 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Does a peptide degrade silently, with no visual change? Replied, post #31 · Practice › Storage & stability · 21 May 2026 · 2 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Alcohol: what is documented and what is folklore Replied, post #10 · Practice › Interactions · 12 May 2026 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #23 · Clinical › Comorbidities · 2 May 2026 · 4 likes PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Started this topic · Clinical › Bloodwork · 27 Apr 2026 · 17 likes Posting this under the heading it deserves: HbA1c lag and what it can and cannot tell you at eight weeks — one year on Everything below is what sits behind that.…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #89 · Research Methods › Statistics · 27 Apr 2026 · 0 likes Picking up post #86: that is the part I would want checked first. Confidence intervals: rather than a single point estimate, a range of plausible values. A narrow…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #15 · Wellbeing › Sleep · 25 Apr 2026 · 9 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #91 · Practice › Reconstitution · 23 Apr 2026 · 30 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #72 · Practice › Reconstitution · 22 Apr 2026 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #38 · Sourcing › Independent verification · 11 Apr 2026 · 0 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #103 · Analytics › Mass spectrometry · 10 Apr 2026 · 2 likes On post #99 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Spike-and-recover accuracy for a peptide assay Replied, post #91 · Analytics › Method validation · 10 Apr 2026 · 1 like Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #85 · Lounge › Introductions · 16 Mar 2026 · 3 likes post #84 is right about the mechanism and I think understates the practical bit. No judgment: people come to this community from all backgrounds and with all…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #15 · Clinical › Bloodwork · 15 Mar 2026 · 5 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
About the Special populations category Replied, post #3 · Clinical › Special populations · 14 Mar 2026 · 33 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #8 · Practice › Interactions · 9 Mar 2026 · 9 likes This follows post #5 rather than contradicting it. Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others…
-
A site rotation scheme that is easy enough to actually follow Replied, post #15 · Practice › Administration · 6 Mar 2026 · 15 likes On post #11 — agreed on the reasoning, with one qualification. Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles.…
-
Five questions in one post gets you one answer — how to split them Replied, post #22 · Start Here › How to Ask · 1 Mar 2026 · 3 likes On post #18 — agreed on the reasoning, with one qualification. Context that matters: compound, how long in, current dose, relevant history. Context that does not…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #24 · Analytics › Impurities & related substances · 23 Feb 2026 · 3 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 16 Feb 2026 · 24 likes post #9 answers the question as asked. The question underneath it is different. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #80 · Documentation › Wiki requests · 9 Feb 2026 · 0 likes I read post #78 twice before replying, because I had assumed the opposite. Correction requests: if you spot an error in a maintained page, note it here with the…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #110 · Sourcing › Independent verification · 5 Feb 2026 · 11 likes Worth separating two things that post #106 runs together. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter…
-
Whether protein timing matters at a large deficit Replied, post #19 · Nutrition & Training › Protein & intake · 24 Jan 2026 · 0 likes I read post #17 twice before replying, because I had assumed the opposite. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit…
-
Search filters: what is missing Replied, post #16 · Meta › Site feedback · 8 Jan 2026 · 4 likes I read post #14 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #82 · Compounds › Semaglutide · 31 Dec 2025 · 16 likes post #81 answers the question as asked. The question underneath it is different. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #78 · Practice › Side effects · 29 Dec 2025 · 10 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Second pass at: Submitting a sample: the process end to end Started this topic · Sourcing › Independent verification · 28 Dec 2025 · 11 likes Second pass at: Submitting a sample: the process end to end Writing it up because I had to work it out twice and would rather nobody else did. A logistics question,…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #84 · Analytics › Home & field testing · 21 Dec 2025 · 26 likes Worth separating two things that post #80 runs together. Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids.…
-
Publishing an inconvenient result: a case study — the long version Replied, post #62 · Sourcing › Independent verification · 7 Dec 2025 · 7 likes post #61 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #3 · Sourcing › Logistics · 1 Dec 2025 · 9 likes Picking up post #2: that is the part I would want checked first. Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #8 · Compounds › Tirzepatide · 30 Nov 2025 · 1 like On post #4 — agreed on the reasoning, with one qualification. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #24 · Compounds › Other compounds · 23 Nov 2025 · 24 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
MHRA statements, read directly Replied, post #29 · Regional › UK & Ireland · 10 Nov 2025 · 9 likes Worth separating two things that post #25 runs together. MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing…
-
[2026 update] What steady state means for the decision to escalate Replied, post #32 · Practice › Dosing & titration · 8 Nov 2025 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Titles that describe the question, not the situation Replied, post #139 · Start Here › How to Ask · 3 Nov 2025 · 30 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #20 · Compounds › Oral incretins · 27 Oct 2025 · 2 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #143 · Practice › Reconstitution · 12 Oct 2025 · 0 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Compounds this community declines to help with, and why Replied, post #80 · Compounds › Other compounds · 7 Oct 2025 · 12 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #37 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why the timeline is on the right and not the left Replied, post #70 · Meta › Site feedback · 18 Sep 2025 · 22 likes Coming back to post #68, because the follow-up matters more than the original answer. Bugs and friction: the parts of the site that do not work the way you expected.…
-
Second pass at: MALDI versus ESI for a quick identity check Started this topic · Analytics › Mass spectrometry · 28 Aug 2025 · 3 likes Second pass at: MALDI versus ESI for a quick identity check Writing it up because I had to work it out twice and would rather nobody else did. Working through the…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #36 · Practice › Administration · 27 Aug 2025 · 2 likes I read post #34 twice before replying, because I had assumed the opposite. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller =…
-
A request that was declined, and the reasoning — a second dataset Replied, post #21 · Documentation › Wiki requests · 7 Aug 2025 · 18 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
Sequence verification for an obscure compound: how it is done Replied, post #114 · Compounds › Other compounds · 3 Aug 2025 · 0 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #41 · Clinical › Special populations · 15 Jul 2025 · 7 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
Counter-ion content and its effect on measured mass Replied, post #84 · Analytics › Mass spectrometry · 6 Jul 2025 · 1 like On post #80 — agreed on the reasoning, with one qualification. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #70 · Compounds › Retatrutide · 26 Jun 2025 · 0 likes I read post #68 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #35 · Practice › Dosing & titration · 18 Jun 2025 · 13 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #12 · Compounds › Oral incretins · 15 Jun 2025 · 10 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
A report I filed that turned out to be wrong, and the correction Replied, post #89 · Sourcing › Vendor reports · 6 Jun 2025 · 6 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
Coming back to: Getting a referral rather than a refusal Replied, post #29 · Clinical › Prescriber conversations · 3 Jun 2025 · 5 likes This follows post #26 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #75 · Practice › Reconstitution · 22 May 2025 · 8 likes On post #71 — agreed on the reasoning, with one qualification. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume…
-
Preparing for an appointment: one page, three questions Replied, post #17 · Clinical › Prescriber conversations · 3 May 2025 · 0 likes On post #13 — agreed on the reasoning, with one qualification. Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #11 · Sourcing › Independent verification · 24 Apr 2025 · 20 likes post #10 is right about the mechanism and I think understates the practical bit. How to submit a sample: contact the service directly. They will provide instructions on…
-
Carryover and the ghost peak from last week's standard Replied, post #17 · Analytics › HPLC & UHPLC · 3 Apr 2025 · 3 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Retatrutide dose escalation in the published trials Replied, post #65 · Compounds › Retatrutide · 29 Mar 2025 · 0 likes This follows post #62 rather than contradicting it. Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the…
-
Coverage for the indication versus for the drug Replied, post #10 · Access › Insurance & coverage · 26 Mar 2025 · 0 likes Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #113 · Compounds › Semaglutide · 23 Mar 2025 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Individual participant data versus aggregate data Replied, post #26 · Evidence › Meta-analyses · 8 Jan 2025 · 32 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #21 · Analytics › Mass spectrometry · 7 Jan 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
When "no data" is the complete and final answer Replied, post #56 · Compounds › Other compounds · 2 Jan 2025 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #104 · Compounds › Oral incretins · 28 Dec 2024 · 0 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #90 · Analytics › Method validation · 8 Dec 2024 · 0 likes This follows post #87 rather than contradicting it. Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #54 · Compounds › Semaglutide · 1 Dec 2024 · 11 likes post #53 answers the question as asked. The question underneath it is different. Albumin binding is not a unique structural feature and nothing in the class lacks it,…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #78 · Clinical › Prescriber conversations · 19 Nov 2024 · 0 likes Picking up post #75: that is the part I would want checked first. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and…
-
When to suspect the method rather than the sample Replied, post #18 · Analytics › Method validation · 30 Sep 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #87 · Sourcing › Independent verification · 26 Sep 2024 · 15 likes This follows post #84 rather than contradicting it. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued…
-
Irish differences from the UK position Replied, post #7 · Regional › UK & Ireland · 24 Sep 2024 · 3 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #121 · Compounds › Retatrutide · 24 Jul 2024 · 15 likes post #120 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Cold packs, phase-change material, and what survives ten days Replied, post #100 · Sourcing › Logistics · 13 Jul 2024 · 17 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Promotion criteria, and the one that stops most nominations Replied, post #12 · Documentation › Doc review · 4 Jul 2024 · 0 likes I read post #10 twice before replying, because I had assumed the opposite. Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here.…